1st Asian-Pacific Workshop on HBV Cure 2026

Preliminary Program

The program of the 1st Asian-Pacific Workshop on HBV Cure 2026 is currently under development.

Our expert faculty are actively curating a dynamic agenda that will feature the latest research, clinical updates, and real-world challenges.

This one-day program will be divided into 4 sessions.

1. Plenary talks on the current status of HBV cure science, appropriate biomarkers and endpoint, viral targets and immunotherapies
2. Presentations of the latest clinical studies and translational research conducted in the region
3. Industry presentations of (pre)clinical data evaluating the most promising drug candidates in their pipeline
4. Panel discussion on the current gaps in HBV cure science, and ways to enhance collaboration